Depression News From Medical News Today

A study published in the current issue of Psychotherapy and Psychosomatics addresses the role of personality factors in moderating treatment response in depression......

Read more

Some anti-depressant drugs are associated with an increased chance of developing cataracts, according to a new statistical study by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute and McGill University......

Read more

Schools are typically on guard against students who bully by inflicting repeated violence on other students. But technology has given rise to a relatively new form of bullying which inflicts emotional harm in a stealth manner, working through Web sites, chat rooms, e-mail, cell phones and instant messaging......

Read more

There's no doubt that meeting partners on the Internet is a growing trend. But can we trust the information that people provide about themselves via online dating services? And why is depression so dissatisfying in relationships? These two questions are explored in articles appearing in the latest issue of the...

Read more

Community support groups can reduce neonatal mortality, and lower rates of maternal depression-provided that the population coverage is wide enough and the programmes are appropriately designed. These are the conclusions of two Articles, published Online First in The Lancet. Participatory women's groups have shown promise in trials...

Read more

Women's community groups have had a dramatic effect on reducing neonatal mortality rates in some of the poorest areas on India, according to a study published in the journal the Lancet. The groups provide a cost-effective intervention with added benefits such as reducing significantly maternal depression and improving decision-making amongst...

Read more

Adults who have both diabetes and major depression are more than twice as likely to develop dementia, compared to adults with diabetes only, according to a study published in the recent Journal of General Internal Medicine. Dementia is the progressive decline of thinking and reasoning abilities......

Read more

Lundbeck Inc. has announced the presentation of results from an open-label extension study of Xenazine® (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD)......

Read more

Counselling Suicidal Clients by Andrew Reeves, from University of Liverpool Counselling Service, is a new title for counselling practitioners published today by SAGE. This title addresses the important professional considerations when working with clients who are suicidal......

Read more

Conventional antidepressant treatments generally require three to four weeks to become effective, thus the discovery of treatments with a more rapid onset is a major goal of biological psychiatry. The first drug found to produce rapid improvement in mood was the NMDA glutamate receptor antagonist, ketamine......

Read more

The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published in Biological Psychiatry. The study is co-authored by Drs. Andrea J. Levinson and Zafiris J. Daskalakis of the Centre for Addiction...

Read more

Research at the Sam and Rose Stein Institute for Research on Aging at the University of California, San Diego School of Medicine suggests a novel route to improving the symptoms of subsyndromal depression (SSD) in seniors through the regular use of "exergames" entertaining video games that combine game play with...

Read more

A study in the March edition of the American Journal of Psychiatry senior-authored by Jerome C......

Read more

Depression raises stress hormone levels in adolescent boys and girls but may lead to obesity only in girls, according to researchers. Early treatment of depression could help reduce stress and control obesity - a major health issue. "This is the first time cortisol reactivity has been identified as a mediator...

Read more

In the United States, nearly 10 percent of the population suffers from a depressive disorder, according to the National Institute of Mental Health. While the causes of depression vary, a new study at the University of Missouri reveals that marital hostility is a contributing factor......

Read more

Acupuncture appears to be an effective way to reduce depression symptoms during pregnancy, according to a first-of-its-kind study from Stanford University School of Medicine researchers......

Read more

Johns Hopkins Children's Center neurovirologist Robert Yolken, M.D., and collaborators from the Stanley Medical Research Institute have developed a large repository of brain and tissue samples to advance the understanding and treatment of bipolar disorder, major depression and schizophrenia......

Read more

Scientists know little about how the brain creates and controls emotions - an uncertainty that presents a major obstacle in the effort to develop treatments for emotional disorders......

Read more

UroToday.com - A report from the Department of Psychiatry, Memorial Sloan-Kettering Cancer Center suggests that African-American (AA) men with prostate cancer (CaP) have a sense of greater emotional well being and lower incidence of clinically significant depressive symptoms compared with Caucasian men......

Read more

More than half of low-income urban mothers met the criteria for a diagnosis of depression at some point between two weeks and 14 months after giving birth, according to a study led by University of Rochester Medical Center researchers and published online by the journal Pediatrics......

Read more

Cancer, the peer-reviewed international journal of the American Cancer Society, has published a study conducted by HealthCore, Inc. in its Jan. 1 edition, demonstrating disparities in breast cancer treatment between commercially insured African-American and white women......

Read more

A group of claimants who were prescribed the diet drug Acomplia (Rimonabant) are bringing proceedings against the manufacturer, Sanofi Aventis, for compensation for depression and suicidal ideation suffered as a result of taking the drug......

Read more

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel glycine site functional partial agonist (GFPA) NMDA receptor modulators, today reported positive top-line results from its Phase I clinical trial of lead compound GLYX-13. GLYX-13 is a GFPA selective modulator...

Read more

Many clinicians believe that depression goes hand in hand with cognitive difficulties such as memory problems or difficulties concentrating and paying attention, but a recent review of nearly 20 years of literature conducted by researchers from UT Southwestern Medical Center has found that depression does not always lead to such...

Read more

People with anxiety and depression are most likely to use a shade of gray to represent their mental state. Researchers writing in the open access journal BMC Medical Research Methodology describe the development of a color chart, The Manchester Color Wheel, which can be used to study people's preferred pigment...

Read more